{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:56:44Z","timestamp":1790791004295,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["2019-0370"],"award-info":[{"award-number":["2019-0370"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016670","name":"Region \u00d6sterg\u00f6tland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016670","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.thromres.2022.03.013","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T21:25:22Z","timestamp":1647552322000},"page":"97-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Associations between hemostatic markers and mortality in COVID-19 \u2013 Compounding effects of D-dimer, antithrombin and PAP complex"],"prefix":"10.1016","volume":"213","author":[{"given":"Niklas","family":"Bokn\u00e4s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cia","family":"Laine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hillarp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit S.","family":"Macwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin M.","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas L.","family":"Lindahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Holmstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10229","key":"10.1016\/j.thromres.2022.03.013_bb0005","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.thromres.2022.03.013_bb0010","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2022.03.013_bb0015","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1111\/jth.14888","article-title":"Incidence of venous thromboembolism in hospitalized patients with COVID-19","volume":"18","author":"Middeldorp","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2022.03.013_bb0020","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.2020006520","article-title":"COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection","volume":"136","author":"Al-Samkari","year":"2020","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.thromres.2022.03.013_bb0025","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.thromres.2022.03.013_bb0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2022.03.013_bb0035","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1186\/s13054-020-03375-7","article-title":"Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients","volume":"24","author":"Jonmarker","year":"2020","journal-title":"Crit. Care"},{"issue":"5","key":"10.1016\/j.thromres.2022.03.013_bb0040","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s11739-020-02394-0","article-title":"Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients","volume":"15","author":"Bazzan","year":"2020","journal-title":"Intern. Emerg. Med."},{"issue":"5","key":"10.1016\/j.thromres.2022.03.013_bb0045","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.7861\/clinmed.2020-0346","article-title":"Von willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?","volume":"20","author":"Ladikou","year":"2020","journal-title":"Clin Med (Lond)."},{"key":"10.1016\/j.thromres.2022.03.013_bb0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.thromres.2020.04.014","article-title":"Severe COVID-19 infection associated with endothelial activation","volume":"190","author":"Escher","year":"2020","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2022.03.013_bb0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/ijlh.13329","article-title":"Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays","volume":"43","author":"White","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"issue":"10","key":"10.1016\/j.thromres.2022.03.013_bb0060","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1111\/jth.15043","article-title":"In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation","volume":"18","author":"Blasi","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2022.03.013_bb0065","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1111\/ijlh.13244","article-title":"Involvement of ADAMTS13 and von willebrand factor in thromboembolic events in patients infected with SARS-CoV-2","volume":"42","author":"Huisman","year":"2020","journal-title":"Int. J. Lab. Hematol."},{"issue":"1","key":"10.1016\/j.thromres.2022.03.013_bb0070","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/ATVBAHA.120.315338","article-title":"COVID-19 and sepsis are associated with different abnormalities in plasma procoagulant and fibrinolytic activity","volume":"41","author":"Bouck","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10234","key":"10.1016\/j.thromres.2022.03.013_bb0075","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.thromres.2022.03.013_bb0080","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.thromres.2022.03.013_bb0085","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-Centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol."},{"issue":"9","key":"10.1016\/j.thromres.2022.03.013_bb0090","article-title":"Endothelial injury and glycocalyx degradation in critically ill coronavirus disease 2019 patients: implications for microvascular platelet aggregation","volume":"2","author":"Fraser","year":"2020","journal-title":"Crit Care Explor."},{"issue":"12","key":"10.1016\/j.thromres.2022.03.013_bb0095","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1161\/ATVBAHA.120.315175","article-title":"Platelets promote thromboinflammation in SARS-CoV-2 pneumonia","volume":"40","author":"Taus","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.thromres.2022.03.013_bb0100","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1111\/jth.14960","article-title":"Fibrinolysis and COVID-19: a plasmin paradox","volume":"18","author":"Medcalf","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2022.03.013_bb0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-2005-922476","article-title":"Validation, calibration, and specificity of quantitative D-dimer assays","volume":"5","author":"Dempfle","year":"2005","journal-title":"Semin. Vasc. Med."},{"issue":"10","key":"10.1016\/j.thromres.2022.03.013_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241329","article-title":"The values of coagulation function in COVID-19 patients","volume":"15","author":"Jin","year":"2020","journal-title":"PLoS One."},{"issue":"11","key":"10.1016\/j.thromres.2022.03.013_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9113487","article-title":"Covid-19-associated coagulopathy: biomarkers of thrombin generation and fibrinolysis leading the outcome","volume":"9","author":"Ranucci","year":"2020","journal-title":"J. Clin. Med."},{"issue":"9","key":"10.1016\/j.thromres.2022.03.013_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092875","article-title":"Hematological phenotype of COVID-19-induced coagulopathy: far from typical sepsis-induced coagulopathy","volume":"9","author":"Umemura","year":"2020","journal-title":"J. Clin. Med."},{"issue":"11","key":"10.1016\/j.thromres.2022.03.013_bb0125","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.03.013_bb0130","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1172\/JCI109931","article-title":"Plasmic degradation of crosslinked fibrin","volume":"66","author":"Francis","year":"1980","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.thromres.2022.03.013_bb0135","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.thromres.2022.03.013_bb0140","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1055\/a-1477-3829","article-title":"Platelet count rose while D-dimer levels dropped as deaths and thrombosis declined-an observational study on anticoagulation shift in COVID-19","volume":"121","author":"Sj\u00f6str\u00f6m","year":"2021","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.03.013_bb0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","article-title":"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy","volume":"191","author":"Lodigiani","year":"2020","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.thromres.2022.03.013_bb0150","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11239-020-02145-0","article-title":"Heparin resistance in COVID-19 patients in the intensive care unit","volume":"50","author":"White","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"issue":"12","key":"10.1016\/j.thromres.2022.03.013_bb0155","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1055\/s-0040-1715841","article-title":"Coagulopathy and thrombosis as a result of severe COVID-19 infection: a microvascular focus","volume":"120","author":"Katneni","year":"2020","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2022.03.013_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051417","article-title":"Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial Disease? A comprehensive evaluation of clinical and basic evidence","volume":"9","author":"Sardu","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.thromres.2022.03.013_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102560","article-title":"Complement activation and endothelial perturbation parallel COVID-19 severity and activity","volume":"116","author":"Cugno","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.thromres.2022.03.013_bb0170","article-title":"The potential role of extracellular vesicles in COVID-19 associated endothelial injury and pro-inflammation","author":"Krishnamachary","year":"2020","journal-title":"medRxiv"},{"issue":"15","key":"10.1016\/j.thromres.2022.03.013_bb0175","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1016\/j.febslet.2005.03.001","article-title":"The anticoagulant protein C pathway","volume":"579","author":"Dahlb\u00e4ck","year":"2005","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.thromres.2022.03.013_bb0180","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1538-7836.2008.03046.x","article-title":"Pulmonary capillary endothelial metabolic function in chronic thromboembolic pulmonary hypertension","volume":"6","author":"Orfanos","year":"2008","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2022.03.013_bb0185","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1182\/blood.V91.2.725","article-title":"Plasma levels of endothelial cell protein C receptor are elevated in patients with sepsis and systemic lupus erythematosus: lack of correlation with thrombomodulin suggests involvement of different pathological processes","volume":"91","author":"Kurosawa","year":"1998","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2022.03.013_bb0190","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-2249.2002.01803.x","article-title":"Plasma levels of soluble endothelial cell protein C receptor in patients with Wegener's granulomatosis","volume":"128","author":"Boomsma","year":"2002","journal-title":"Clin. Exp. Immunol."},{"issue":"11","key":"10.1016\/j.thromres.2022.03.013_bb0195","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.3201\/eid2611.191694","article-title":"Endotheliopathy and platelet dysfunction as hallmarks of fatal Lassa fever","volume":"26","author":"Horton","year":"2020","journal-title":"Emerg. Infect. Dis."},{"issue":"21","key":"10.1016\/j.thromres.2022.03.013_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218234","article-title":"Erythrocyte, platelet, serum ferritin, and P-selectin pathophysiology implicated in severe hypercoagulation and vascular complications in COVID-19","volume":"21","author":"Venter","year":"2020","journal-title":"Int. J. Mol. Sci."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822000901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822000901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:47:59Z","timestamp":1758736079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384822000901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":40,"alternative-id":["S0049384822000901"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2022.03.013","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between hemostatic markers and mortality in COVID-19 \u2013 Compounding effects of D-dimer, antithrombin and PAP complex","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2022.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}